SI2138169T1 - Sistem za transdermalno dostavo hormonov brez pospeĹˇevalcev penetracije - Google Patents

Sistem za transdermalno dostavo hormonov brez pospeĹˇevalcev penetracije

Info

Publication number: SI2138169T1
Authority: SI; Slovenia
Prior art keywords: hormones; delivery system; transdermal delivery; penetration promoters; promoters
Prior art date: 2003-12-12

Application number

SI200432127T

Other languages

English (en)

Inventor

Thomas Langguth

Michael Dittgen

Stefan Bracht

Petra Huber

Dirk Schenk

Original Assignee

Bayer Intellectual Property Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-12-12

Filing date

2004-12-10

Publication date

2014-03-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34924031&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2138169(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-12-10 Application filed by Bayer Intellectual Property Gmbh filed Critical Bayer Intellectual Property Gmbh

2014-03-31 Publication of SI2138169T1 publication Critical patent/SI2138169T1/sl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Endocrinology (AREA)
Gynecology & Obstetrics (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Botany (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

SI200432127T 2003-12-12 2004-12-10 Sistem za transdermalno dostavo hormonov brez pospeĹˇevalcev penetracije SI2138169T1 (sl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP03078881		2003-12-12
EP09173898.9A EP2138169B1 (en)	2003-12-12	2004-12-10	Transdermal delivery system of hormones without penetration enhancers

Publications (1)

Publication Number	Publication Date
SI2138169T1 true SI2138169T1 (sl)	2014-03-31

Family

ID=34924031

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SI200431404T SI1541137T1 (sl)	2003-12-12	2004-12-10	Transdermalni dajalni sistem gestodena
SI200432127T SI2138169T1 (sl)	2003-12-12	2004-12-10	Sistem za transdermalno dostavo hormonov brez pospeĹˇevalcev penetracije

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
SI200431404T SI1541137T1 (sl)	2003-12-12	2004-12-10	Transdermalni dajalni sistem gestodena

Country Status (23)

Country	Link
EP (2)	EP2138169B1 (sl)
CN (1)	CN101843603B (sl)
AR (1)	AR046762A1 (sl)
AT (1)	ATE457168T1 (sl)
CR (1)	CR8465A (sl)
CY (2)	CY1110637T1 (sl)
DE (1)	DE602004025444D1 (sl)
DK (2)	DK2138169T3 (sl)
ES (2)	ES2340925T3 (sl)
GT (1)	GT200400262A (sl)
HN (1)	HN2004000526A (sl)
HR (2)	HRP20100254T1 (sl)
JO (1)	JO2606B1 (sl)
ME (1)	ME01069B (sl)
MY (2)	MY144053A (sl)
PE (1)	PE20051035A1 (sl)
PL (2)	PL2138169T3 (sl)
PT (2)	PT2138169E (sl)
RS (2)	RS51260B (sl)
SI (2)	SI1541137T1 (sl)
SV (1)	SV2006001970A (sl)
TW (1)	TWI257299B (sl)
UA (1)	UA89766C2 (sl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT1594483E (pt)	2003-02-21	2006-12-29	Schering Ag	Penso transdérmico estável aos uv
US8668925B2 (en)	2003-12-12	2014-03-11	Bayer Intellectual Property Gmbh	Transdermal delivery of hormones without the need of penetration enhancers
US8962013B2 (en)	2005-05-02	2015-02-24	Bayer Intellectual Property Gmbh	Multi-layered transdermal system with triazine UV absorber
DE102005050729A1 (de) *	2005-10-19	2007-04-26	Schering Ag	Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption
WO2010042610A1 (en)	2008-10-08	2010-04-15	Agile Therapeutics, Inc.	Transdermal delivery
CA2740002C (en)	2008-10-08	2016-11-01	Agile Therapeutics, Inc.	Transdermal delivery
CA2740005C (en)	2008-10-08	2016-11-01	Agile Therapeutics, Inc.	Transdermal delivery
EP2410859A4 (en)	2009-03-27	2013-03-13	Agile Therapeutics Inc	TRANSDERMAL ADMINISTRATION
DE102010040299A1 (de) *	2010-09-06	2012-03-08	Bayer Schering Pharma Aktiengesellschaft	Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
AU2015203180B2 (en) *	2010-09-06	2016-06-30	Bayer Intellectual Property Gmbh	Transdermal therapeutic systems with crystallization-inhibiting protective film (release liner)
HRP20170292T1 (hr)	2010-09-06	2017-04-21	Bayer Intellectual Property Gmbh	Transdermalni flasteri niske doze s visokim otpuštanjem lijeka
HK1204287A1 (en) *	2012-01-27	2015-11-13	敏捷治疗公司	Transdermal hormone delivery

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4081537A (en)	1975-10-10	1978-03-28	Schering Aktiengesellschaft	Δ15 -Steroids and pharmaceutical compositions thereof
JP3238389B2 (ja) *	1988-10-27	2001-12-10	シエーリングアクチエンゲゼルシヤフト	ゲストデン含有の経皮適用のための薬剤
PT99338A (pt)	1990-10-29	1992-10-30	Alza Corp	Processo para a preparacao de composicoes de farmacos anticoncepcionais administradas transdermicamente contendo uma mistura dum estrogeno e gestodeno e dispositivos para a sua administracao transdermica
US5512292A (en)	1990-10-29	1996-04-30	Alza Corporation	Transdermal contraceptive formulations methods and devices
DE4336557C2 (de)	1993-05-06	1997-07-17	Lohmann Therapie Syst Lts	Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
DE4329242A1 (de) *	1993-08-26	1995-03-02	Schering Ag	Mittel zur transdermalen Applikation enthaltend Gestodenester
DE4405898A1 (de)	1994-02-18	1995-08-24	Schering Ag	Transdermale therapeutische Systeme enthaltend Sexualsteroide
US5762956A (en)	1996-04-24	1998-06-09	Rutgers, The State University Of New Jersey	Transdermal contraceptive delivery system and process
DE19906152B4 (de)	1999-02-10	2005-02-10	Jenapharm Gmbh & Co. Kg	Wirkstoffhaltige Laminate für Transdermalsysteme
EP1242012B1 (en)	1999-11-24	2009-12-30	Agile Therapeutics, Inc.	Improved transdermal contraceptive delivery system and process
DE10053375C1 (de) *	2000-10-27	2002-01-24	Lohmann Therapie Syst Lts	Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen
TWI287455B (en)	2000-12-05	2007-10-01	Noven Pharma	Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use

2004
- 2004-10-12 UA UAA200607580A patent/UA89766C2/ru unknown
- 2004-11-18 JO JO2004159A patent/JO2606B1/en active
- 2004-12-10 SV SV2004001970A patent/SV2006001970A/es not_active Application Discontinuation
- 2004-12-10 PL PL09173898T patent/PL2138169T3/pl unknown
- 2004-12-10 SI SI200431404T patent/SI1541137T1/sl unknown
- 2004-12-10 ES ES04078365T patent/ES2340925T3/es not_active Expired - Lifetime
- 2004-12-10 AT AT04078365T patent/ATE457168T1/de active
- 2004-12-10 AR ARP040104605A patent/AR046762A1/es not_active Application Discontinuation
- 2004-12-10 DK DK09173898.9T patent/DK2138169T3/da active
- 2004-12-10 EP EP09173898.9A patent/EP2138169B1/en not_active Expired - Lifetime
- 2004-12-10 RS RSP-2010/0202A patent/RS51260B/sr unknown
- 2004-12-10 MY MYPI20045107A patent/MY144053A/en unknown
- 2004-12-10 PT PT91738989T patent/PT2138169E/pt unknown
- 2004-12-10 TW TW093138443A patent/TWI257299B/zh not_active IP Right Cessation
- 2004-12-10 DE DE602004025444T patent/DE602004025444D1/de not_active Expired - Lifetime
- 2004-12-10 PT PT04078365T patent/PT1541137E/pt unknown
- 2004-12-10 GT GT200400262A patent/GT200400262A/es unknown
- 2004-12-10 PE PE2004001230A patent/PE20051035A1/es active IP Right Grant
- 2004-12-10 ES ES09173898.9T patent/ES2445690T3/es not_active Expired - Lifetime
- 2004-12-10 SI SI200432127T patent/SI2138169T1/sl unknown
- 2004-12-10 PL PL04078365T patent/PL1541137T3/pl unknown
- 2004-12-10 ME MEP-2010-79A patent/ME01069B/me unknown
- 2004-12-10 CN CN2010101564978A patent/CN101843603B/zh not_active Expired - Lifetime
- 2004-12-10 DK DK04078365.6T patent/DK1541137T3/da active
- 2004-12-10 HN HN2004000526A patent/HN2004000526A/es unknown
- 2004-12-10 EP EP04078365A patent/EP1541137B1/en not_active Expired - Lifetime
- 2004-12-10 RS YU20140050A patent/RS53182B/sr unknown
2006
- 2006-06-20 CR CR8465A patent/CR8465A/es unknown
2010
- 2010-03-31 MY MYPI2010001448 patent/MY152750A/en unknown
- 2010-05-04 HR HR20100254T patent/HRP20100254T1/hr unknown
- 2010-05-07 CY CY20101100401T patent/CY1110637T1/el unknown
2014
- 2014-01-24 HR HRP20140077TT patent/HRP20140077T1/hr unknown
- 2014-02-06 CY CY20141100099T patent/CY1115064T1/el unknown

Also Published As

Publication number	Publication date
CN101843603B (zh)	2012-06-27
PT1541137E (pt)	2010-05-17
ATE457168T1 (de)	2010-02-15
CN101843603A (zh)	2010-09-29
EP2138169A3 (en)	2011-04-06
EP1541137B1 (en)	2010-02-10
CR8465A (es)	2007-06-06
HK1074801A1 (en)	2005-11-25
PL1541137T3 (pl)	2010-07-30
JO2606B1 (en)	2011-11-01
ES2340925T3 (es)	2010-06-11
CY1110637T1 (el)	2015-04-29
EP1541137A3 (en)	2005-11-16
CY1115064T1 (el)	2016-12-14
PE20051035A1 (es)	2006-02-08
MY152750A (en)	2014-11-28
DK1541137T3 (da)	2010-04-26
MY144053A (en)	2011-08-15
ME01069B (me)	2012-10-20
HRP20140077T1 (hr)	2014-02-28
EP1541137A2 (en)	2005-06-15
EP2138169B1 (en)	2013-11-06
PL2138169T3 (pl)	2014-04-30
DE602004025444D1 (de)	2010-03-25
DK2138169T3 (da)	2013-11-18
AR046762A1 (es)	2005-12-21
SV2006001970A (es)	2006-02-16
HK1132682A1 (en)	2010-03-05
HRP20100254T1 (hr)	2010-06-30
HN2004000526A (es)	2010-02-01
ES2445690T3 (es)	2014-03-04
RS51260B (sr)	2010-12-31
TWI257299B (en)	2006-07-01
RS53182B (sr)	2014-06-30
GT200400262A (es)	2005-10-31
TW200528073A (en)	2005-09-01
SI1541137T1 (sl)	2010-06-30
EP2138169A2 (en)	2009-12-30
UA89766C2 (en)	2010-03-10
PT2138169E (pt)	2014-02-17

Publication	Publication Date	Title
AT500095B1 (de)	2006-05-15	Transdermales abgabesystem
ATE498412T1 (de)	2011-03-15	System zur abgabe von flüchtigen stoffen
EP1802258A4 (en)	2015-09-23	BIOSYNCHRONE TRANSDERMAL MEDICINES
EP1789630A4 (en)	2009-07-22	TRANSPORT SYSTEM
EP1773439A4 (en)	2010-01-20	MATERIAL DISTRIBUTION SYSTEM
DK1530965T3 (da)	2006-07-17	Kontrolleret frigivelsesleveringssystem til nasal applikation
DK1891962T3 (da)	2014-10-13	Glutathion-baseret afgivelsessystem
EP1800085A4 (en)	2011-05-04	DELIVERY SYSTEM
EP1720605A4 (en)	2007-10-24	TRANSDERMAL DELIVERY SYSTEM FOR COSMETIC AGENTS
IL181436A0 (en)	2007-07-04	Transdermal antiemesis delivery system, method and composition therefor
IL190245A0 (en)	2008-11-03	Iontophoretic drug delivery system
GB0426641D0 (en)	2005-01-05	Protein delivery system
EP1768742A4 (en)	2007-10-17	ADMINISTRATION SYSTEM FOR TRANSDERMAL IMMUNIZATION
SI2138169T1 (sl)	2014-03-31	Sistem za transdermalno dostavo hormonov brez pospeĹˇevalcev penetracije
EP1740497A4 (en)	2015-11-11	SYSTEMS, DEVICES AND METHODS FOR ELECTROKINETIC RELOCATION OF MEDICAMENT
GB0517035D0 (en)	2005-09-28	Delivery system
GB0810016D0 (en)	2008-07-09	Method and system for transdermal drug delivery
DE502005004128D1 (de)	2008-06-26	Alkaloidhaltiges futtermittel bzw. futtermittelzusatz
IL176112A0 (en)	2006-10-05	Transdermal delivery system of hormones without penetration enhancers
DE502005004949D1 (de)	2008-09-18	Rückhaltesystem
GB0517838D0 (en)	2005-10-12	Transdermal active principle delivery means
GB0401008D0 (en)	2004-02-18	Drug delivery system
DK1630468T3 (da)	2013-03-25	Pumpesystem
FIU20040334U0 (fi)	2004-09-15	Virtuaali-ikkunajärjestelmä
SE0401134D0 (sv)	2004-05-03	System för avgradning